Sankalp Arora, Hematology/Oncology Fellow at the MD Anderson Cancer Center, shared on X/Twitter:
“Excited to be presenting retrospective data from MD Anderson Cancer Center at EHA24 describing outcomes of PICALM::MLLT10 fusion acute leukemias!
Key takeaways:
– PICALM::MLLT10 fusion leads to acute leukemias with myeloid/lymphoid/mixed phenotype
– Immature cells with mixed immunophenotype and lineage infidelity
– High frequency of Extramedullary disease
– Low response rates to standard induction therapies.”
Visit the article website.
Source: Sankalp Arora/X